WAT
Waters Corp
$
288.760
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
300.760
Open
295.010
VWAP
292.12
Vol
1.37M
Mkt Cap
17.19B
Low
287.850
Amount
401.53M
EV/EBITDA(TTM)
18.16
Total Shares
59.32M
EV
18.88B
EV/OCF(TTM)
24.88
P/S(TTM)
5.98
Waters Corporation offers analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences. The Company's segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates directly in over 35 countries and has products available in more than 100 countries.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
748.32M
+5.62%
2.946
+12.01%
775.71M
+4.78%
3.240
+10.57%
926.90M
+6.21%
4.516
+10.14%
Estimates Revision
The market is revising Upward the revenue expectations for Waters Corporation (WAT) for FY2025, with the revenue forecasts being adjusted by 1.03% over the past three months. During the same period, the stock price has changed by -15.53%.
Revenue Estimates for FY2025
Revise Upward
+1.03%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+0.64%
In Past 3 Month
Stock Price
Go Down
-15.53%
In Past 3 Month
13 Analyst Rating
32.45% Upside
Wall Street analysts forecast WAT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WAT is 382.45 USD with a low forecast of 330.00 USD and a high forecast of 465.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Buy
7 Hold
0 Sell
Moderate Buy
32.45% Upside
Current: 288.760
Low
330.00
Averages
382.45
High
465.00
32.45% Upside
Current: 288.760
Low
330.00
Averages
382.45
High
465.00
Baird
Catherine Ramsey Schulte
Outperform -> Outperform
downgrade
$374 -> $352
2025-07-16
Reason
Baird
Catherine Ramsey Schulte
Price Target
$374 -> $352
2025-07-16
downgrade
Outperform -> Outperform
Reason
Baird analyst Catherine Ramsey Schulte lowered the firm's price target on Waters to $352 from $374 and keeps an Outperform rating on the shares. The firm updated its model after valuing the new combined model of it and its acquisition of the Becton Dickinson Biosciences & Dx assets.
BofA
Neutral
downgrade
$375 -> $335
2025-07-15
Reason
BofA
Price Target
$375 -> $335
2025-07-15
downgrade
Neutral
Reason
BofA lowered the firm's price target on Waters (WAT) to $335 from $375 and keeps a Neutral rating on the shares after the company announced an agreement to combine with a Becton Dickinson (BDX) unit. The firm views potential synergies from the deal as a major debate and says a "skeptical reception" drove a selloff in Waters shares.
Wells Fargo
Brandon Couillard
Overweight -> Equal Weight
downgrade
$420 -> $330
2025-07-15
Reason
Wells Fargo
Brandon Couillard
Price Target
$420 -> $330
2025-07-15
downgrade
Overweight -> Equal Weight
Reason
Wells Fargo analyst Brandon Couillard downgraded Waters to Equal Weight from Overweight with a price target of $330, down from $420. The firm says that Waters' (WAT) acquisition of Becton Dickinson's (BDX) Biosciences & Dx assets has sound strategic merit, but given the deal size, Wells thinks concerns on execution risk could keep shares range-bound and cap its relative valuation premium.
BofA
Neutral
downgrade
$375 -> $330
2025-07-15
Reason
BofA
Price Target
$375 -> $330
2025-07-15
downgrade
Neutral
Reason
BofA lowered the firm's price target on Waters (WAT) to $330 from $375 and keeps a Neutral rating on the shares after the company announced an agreement to combine with a Becton Dickinson (BDX) unit. The firm views potential synergies from the deal as a major debate and says a "skeptical reception" drove a selloff in Waters shares.
Jefferies
Buy
maintain
$306.92
2025-07-14
Reason
Jefferies
Price Target
$306.92
2025-07-14
maintain
Buy
Reason
Jefferies expects shares of Waters (WAT) to trade down on the combination with Beckton Dickinson (BDX) via a reverse merger trust due to the deal size and \"variables added to a clean replacement cycle story.\" However, longer term, Jefferies likes the merits of the deal, saying it creates real scale, which has proven effective in the space. It keeps a Buy rating on Waters, which is trading down 13% to $306.92 in morning trading.
BofA
Michael Ryskin
Neutral
maintain
$370 -> $375
2025-06-26
Reason
BofA
Michael Ryskin
Price Target
$370 -> $375
2025-06-26
maintain
Neutral
Reason
BofA analyst Michael Ryskin raised the firm's price target on Waters to $375 from $370 and keeps a Neutral rating on the shares. The firm is updating its price targets for stocks under its coverage in the Life Sciences & Diagnostic Tools, LSTs, sector, the analyst tells investors. The firm notes LSTs remain under pressure as uncertainty persists with the macro environment and U.S. government policies. Recent weeks, however, have seen some signs of improvement as tariff concerns have cools slightly, the firm adds.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Waters Corp (WAT.N) is 22.44, compared to its 5-year average forward P/E of 26.95. For a more detailed relative valuation and DCF analysis to assess Waters Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Undervalued
5Y Average PE
26.95
Current PE
22.44
Overvalued PE
30.59
Undervalued PE
23.32
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Undervalued
5Y Average EV/EBITDA
19.84
Current EV/EBITDA
16.59
Overvalued EV/EBITDA
22.37
Undervalued EV/EBITDA
17.31
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
6.49
Current PS
5.64
Overvalued PS
7.38
Undervalued PS
5.59
Financials
Annual
Quarterly
FY2025Q1
YoY :
+3.90%
661.71M
Total Revenue
FY2025Q1
YoY :
+5.31%
151.75M
Operating Profit
FY2025Q1
YoY :
+18.77%
121.38M
Net Income after Tax
FY2025Q1
YoY :
+18.02%
2.03
EPS - Diluted
FY2025Q1
YoY :
-0.17%
233.81M
Free Cash Flow
FY2025Q1
YoY :
-1.09%
56.41
Gross Profit Margin - %
FY2025Q1
YoY :
+17.49%
20.76
FCF Margin - %
FY2025Q1
YoY :
+14.27%
18.34
Net Margin - %
FY2025Q1
YoY :
-17.37%
21.46
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 125.8% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
928.5K
Volume
8
6-9
Months
411.2K
Volume
9
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
4
129.9K
Volume
Months
6-9
7
79.8K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
8.0K
USD
1
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
1
8.0K
USD
Months
3-6
0
0.0
USD
Months
6-9
1
8.0K
USD
Months
0-12
1
8.0K
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
WAT News & Events
Events Timeline
2025-07-14 (ET)
2025-07-14
12:01:01
Waters falls -11.7%
2025-07-14
10:29:20
Leerink says Waters to bank on disciplined execution in longer run after deal
2025-07-14
10:21:24
Waters, BD Bioscience deal 'looks to be a good fit,' says Stifel
Sign Up For More Events
Sign Up For More Events
News
7.0
07-26GlobenewswireSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRGX, WAT, CORZ on Behalf of Shareholders
2.0
07-20BenzingaSchlumberger, Stellantis And ASML Holding Are Among Top 10 Large Cap Losers Last Week (July 14-July 18): Are The Others In Your Portfolio?
3.0
07-19CNBCNvidia and other stocks just became the most overbought names on Wall Street this week
Sign Up For More News
People Also Watch
IX
ORIX Corp
22.550
USD
+0.13%
KB
KB Financial Group Inc
79.150
USD
-1.44%
HUBB
Hubbell Inc
437.480
USD
+0.01%
GFS
GlobalFoundries Inc
37.390
USD
-5.20%
EME
EMCOR Group Inc
627.490
USD
-1.85%
ON
ON Semiconductor Corp
56.360
USD
-2.91%
ROL
Rollins Inc
57.270
USD
-0.64%
RKT
Rocket Companies Inc
14.770
USD
+0.75%
WBD
Warner Bros Discovery Inc
13.170
USD
-0.68%
LII
Lennox International Inc
609.000
USD
-1.07%
FAQ
What is Waters Corp (WAT) stock price today?
The current price of WAT is 288.76 USD — it has decreased -3.45 % in the last trading day.
What is Waters Corp (WAT)'s business?
What is the price predicton of WAT Stock?
What is Waters Corp (WAT)'s revenue for the last quarter?
What is Waters Corp (WAT)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Waters Corp (WAT)'s fundamentals?
How many employees does Waters Corp (WAT). have?